Strategic management paper for Boehriger Ingelheim Philippines
Date of Publication
2006
Document Type
Oral Comprehensive Exam
Degree Name
Master of Business Administration
College
Ramon V. Del Rosario College of Business
Department/Unit
Decision Sciences and Innovation
Defense Panel Chair
Louie A. Divinagracia
Defense Panel Member
Benjamin Espiritu
Tristan H. Macapanpan
Abstract/Summary
Boehringer Ingelheim Philippines is a wholly-owned subsidiary of Boehringer Ingelheim International GmBH, with headquarters in the city of Ingelheim am Rhein, Germany. Boehringer Ingelheim Philippines belongs to the Australasia section
Boehringer Ingelheim Phil, Inc. (BIPHI) is one of the leading pharmaceutical companies in the Philippines. It markets human and animal health products (prescription medicines, consumer health products and animal vaccines) that are known for their quality and efficacy. The human pharmaceuticals business accounts for 95 percent (70.2% Prescription Medicines and 24.8% CHC) of the company's total revenue while the animal health division accounts for only 5%. The product line of Boehringer Ingelheim, (Phil.) Inc. is composed of cardiovascular, respiratory and neurological medicines.
Boehringer Ingelheim, Phils. is divided into three divisions the Prescription Medicines Division, Consumer Health Care Division and the Animal Health Division. The Consumer Health Care Division markets OTC (over-the-counter) drugs such as Pharmaton, Dulcolax, Kiddi Pharmaton, and Bisolvon.
The Prescription Medicines Division (Ethical) presently markets drugs such as Mucosolvan, Spiriva, Micardis, Micardis Plus, Sifrol, Mobic, Primavent, Persantin, Berodual, Combivent UDV, Aggrenox and Buscopan.
The Animal Health Division markets animal vaccines such as Ingelvac, Enterisol, Reprocycle, Volvac and Bar Somnus.
Abstract Format
html
Language
English
Format
Electronic
Accession Number
CDOCE00951
Shelf Location
Archives, The Learning Commons, 12F Henry Sy Sr. Hall
Physical Description
1 computer optical disc ; 4 3/4 in.
Keywords
Pharmaceutical industry--Philippines; Veterinary drug industry--Philippines; Boehriger Ingelheim Philippines
Recommended Citation
Guilas, C. L. (2006). Strategic management paper for Boehriger Ingelheim Philippines. Retrieved from https://animorepository.dlsu.edu.ph/etd_masteral/3644